Hap Trading, LLC 180 Life Sciences Corp. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$0.12 - $1.31 $1,440 - $15,720	-12,000 Reduced 35.09%	22,200 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.81 - $2.53 $11,502 - $35,926	14,200 Added 71.0%	34,200 $2,000
Q1 2022 May 12, 2022	SELL	$2.53 - $3.9 $17,710 - $27,300	-7,000 Reduced 25.93%	20,000 $8,000
Q4 2021 Feb 14, 2022	SELL	$3.27 - $6.38 $41,856 - $81,664	-12,800 Reduced 32.16%	27,000 $3,000
Q3 2021 Nov 10, 2021	BUY	$5.11 - $10.81 $75,117 - $158,907	14,700 Added 58.57%	39,800 $12,000
Q2 2021 Aug 11, 2021	BUY	$6.7 - $11.98 $54,270 - $97,038	8,100 Added 47.65%	25,100 $12,000
Q1 2021 May 14, 2021	BUY	$2.51 - $6.96 $42,670 - $118,320	17,000 New	17,000 $12,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.